The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease

Hölscher, C., 02/2014, In: Alzheimer's and Dementia. 10, 1 Supplement, p. S47-54 8 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse Model

Panagaki, T., Gengler, S. & Hölscher, C., 16/10/2018, In: Journal of Alzheimer's Disease. 66, 1, p. 195-218 24 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

The role of GLP-1 in neuronal activity and neurodegeneration

Hölscher, C., 2010, In: Vitamins and Hormones. 84, p. 331-354 24 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain

Parthsarathy, V. & Hölscher, C., 30/01/2013, In: European Journal of Pharmacology. 700, 1-3, p. 42-50 9 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease

Li, Y., Zhao, J. & Holscher, C., 08/2017, In: CNS Drugs. 31, 8, p. 639-652 14 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Therapeutic potential of flavonoids in spinal cord injury

Zhang, P., Holscher, C. & Ma, X., 01/2017, In: Reviews in the Neurosciences. 28, 1, p. 87-101 15 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Therapeutic potential of genipin in central neurodegenerative diseases

Li, Y., Li, L. & Holscher, C., 10/2016, In: CNS Drugs. 30, 10, p. 889-897 9 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-Amyloid oligomers in mice and monkeys

Lourenco, M. V., Clarke, J. R., Frozza, R. L., Bomfim, T. R., Forny-Germano, L., Batista, A. F., Sathler, L. B., Brito-Moreira, J., Amaral, O. B., Silva, C. A., Freitas-Correa, L., Espírito-Santo, S., Campello-Costa, P., Houzel, J-C., Klein, W. L., Holscher, C., Carvalheira, J. B., Silva, A. M., Velloso, L. A., Munoz, D. P., & 2 othersFerreira, S. T. & De Felice, F. G., 3/12/2013, In: Cell Metabolism. 18, 6, p. 831-843 13 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease

Feng, P., Zhang, X., Li, D., Ji, C., Yuan, Z., Wang, R., Xue, G., Li, G. & Hölscher, C., 1/05/2018, In: Neuropharmacology. 133, p. 385-394 10 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease

Graham, S. F., Chevallier, O. P., Elliott, C. T., Holscher, C., Johnston, J., McGuinness, B., Kehoe, P. G., Passmore, A. P. & Green, B. D., 24/03/2015, In: PLoS ONE. 10, 3, 16 p., e0119452.

Research output: Contribution to Journal/Magazine › Journal article › peer-review